30 Participants Needed

Fetoscopic Repair for Spina Bifida

Recruiting at 1 trial location
JB
Overseen ByJena B Miller, MD
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this investigation is to evaluate maternal and fetal outcomes following fetoscopic repair of fetal spina bifida at the Johns Hopkins Hospital. The hypothesis of this study is that fetoscopic spina bifida repair is feasible and has the same effectiveness as open repair of fetal spina bifida, but with the benefit of significantly lower maternal and fetal complication rates. The fetal benefit of the procedure will be the prenatal repair of spina bifida. The maternal benefit of fetoscopic spina bifida repair will be the avoidance of a large uterine incision. This type of incision increases the risk of uterine rupture and requires that all future deliveries are by cesarean section. The use of the minimally invasive fetoscopic surgical technique may also lower the risk of preterm premature rupture of membranes and preterm birth compared to open fetal surgery. Finally, successful fetoscopic spina bifida repair also makes vaginal delivery possible.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Fetoscopic Repair for Spina Bifida?

Research suggests that fetoscopic repair for spina bifida can improve neurological outcomes for babies after birth and reduce risks for mothers compared to open fetal surgery. It seems to achieve similar postnatal results as open repair but with less trauma to the mother.12345

How does the fetoscopic repair treatment for spina bifida differ from other treatments?

Fetoscopic repair for spina bifida is a minimally invasive treatment that aims to improve neurological outcomes for the baby while reducing trauma to the mother compared to traditional open fetal surgery. It involves using small instruments and a camera inserted through tiny incisions, which minimizes the risk of complications like uterine rupture in future pregnancies.14567

Research Team

JM

Jena B Miller, MD

Principal Investigator

Johns Hopkins University

Eligibility Criteria

This trial is for pregnant women aged 18 or older with a single baby diagnosed with isolated fetal spina bifida, where the defect is between T1-S1 vertebrae. The pregnancy should be between 19 to almost 26 weeks along, and the fetus must have a normal karyotype. Women under 18, carrying multiples, having additional fetal anomalies, facing technical issues for surgery, placenta previa or certain maternal health risks are excluded.

Inclusion Criteria

Gestational age between 19+0 to 25+6 weeks gestation
Normal fetal karyotype
I am a pregnant woman, 18 or older, and can give consent.
See 2 more

Exclusion Criteria

Preterm labor
Cervical length < 25mm
Maternal Beck Depression Inventory score ≥ 17
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Fetoscopic Repair

Participants undergo fetoscopic repair of fetal spina bifida

Up to 21 weeks
Surgery and monitoring visits

Follow-up

Participants are monitored for safety and effectiveness after fetoscopic repair

Up to 28 days post-birth
Regular monitoring visits

Early Childhood Follow-up

Monitoring of early childhood outcomes including motor function and neurodevelopmental assessments

Up to 30 months of age

Treatment Details

Interventions

  • Fetoscopic Repair
Trial Overview The study at Johns Hopkins Hospital is testing fetoscopic repair of fetal spina bifida—a minimally invasive surgery expected to be as effective as open repair but with fewer complications. Benefits may include lower risk of uterine rupture in future pregnancies and possibly allowing vaginal birth.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: FetoscopyExperimental Treatment1 Intervention
All participants will undergo fetoscopic repair of fetal spina bifida.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

Findings from Research

Minimally invasive fetoscopic surgery for spina bifida aims to enhance the neurological outcomes for affected fetuses while reducing maternal trauma compared to traditional open fetal surgery.
The article provides insights into the perioperative and postoperative management practices for these cases, highlighting the advancements in surgical techniques for better patient care.
[Peri- and postoperative management for minimally invasive fetoscopic surgery of spina bifida].Degenhardt, J., Axt-Fliedner, R., Enzensberger, C., et al.[2014]
The fetoscopic surgical approach for repairing myelomeningocele resulted in significantly better maternal and neonatal outcomes compared to the open approach, including fewer cases of preterm birth, neonatal death, and neurodevelopmental disabilities in both the index and subsequent pregnancies.
Although the fetoscopic technique was more expensive, it was deemed cost-effective, with an incremental cost-effectiveness ratio of $1029 per quality-adjusted life year, indicating that the improved outcomes justify the higher costs in a theoretical cohort of 500 women.
Fetoscopic compared with open repair of myelomeningocele: a 2-delivery cost-effectiveness analysis.Packer, CH., Hersh, AR., Caughey, AB.[2021]
In a study involving 7 women with spina bifida aperta, laparotomy-assisted fetoscopic repair was performed successfully without fetal demise, demonstrating its potential as a safe prenatal surgical option.
The procedure resulted in watertight repairs at birth for most cases, with some needing postnatal surgery; however, 50% of the infants required shunting within 6 months, indicating the need for careful monitoring post-surgery.
Laparotomy-Assisted 2-Port Fetoscopic Repair of Spina Bifida Aperta: Report of a Single-Center Experience in Paris, France.Arthuis, C., James, S., Bussieres, L., et al.[2023]

References

[Peri- and postoperative management for minimally invasive fetoscopic surgery of spina bifida]. [2014]
Fetoscopic compared with open repair of myelomeningocele: a 2-delivery cost-effectiveness analysis. [2021]
Laparotomy-Assisted 2-Port Fetoscopic Repair of Spina Bifida Aperta: Report of a Single-Center Experience in Paris, France. [2023]
Fetoscopic Open Neural Tube Defect Repair: Development and Refinement of a Two-Port, Carbon Dioxide Insufflation Technique. [2022]
Endoscopic fetal surgery for neural tube defects. [2020]
Implementation Process and Evolution of a Laparotomy-Assisted 2-Port Fetoscopic Spina Bifida Closure Program. [2021]
Percutaneous minimally invasive fetoscopic surgery for spina bifida aperta. Part III: neurosurgical intervention in the first postnatal year. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security